Searching News Database: Cyberonics
HSMN NewsFeed - 9 Oct 2015
Sorin And Cyberonics Announce Appointment Of Remaining Post-Merger Directors Of Combined Company
Sorin And Cyberonics Announce Appointment Of Remaining Post-Merger Directors Of Combined Company
HSMN NewsFeed - 12 May 2015
Sorin And Cyberonics Announce Executive Leadership Team For The New Company Upon Close Of Merger
Sorin And Cyberonics Announce Executive Leadership Team For The New Company Upon Close Of Merger
HSMN NewsFeed - 28 Apr 2014
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
HSMN NewsFeed - 20 Feb 2014
Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy(R)
Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy(R)
HSMN NewsFeed - 12 Sep 2013
Cyberonics Names Rohan J. Hoare, Ph.D. Senior Vice President, Strategic Planning
Cyberonics Names Rohan J. Hoare, Ph.D. Senior Vice President, Strategic Planning
HSMN NewsFeed - 9 Jan 2013
Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies
Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies
HSMN NewsFeed - 4 May 2012
OrthoAccel Technologies, Inc. Announces New Chief Innovation Officer and Vice President of Marketing
OrthoAccel Technologies, Inc. Announces New Chief Innovation Officer and Vice President of Marketing
HSMN NewsFeed - 28 Feb 2012
James Reinstein Appointed President and Chief Executive Officer of Aptus Endosystems
James Reinstein Appointed President and Chief Executive Officer of Aptus Endosystems
HSMN NewsFeed - 3 Jan 2012
Cyberonics Announces FDA Approval of Re-Designed AspireHC(TM) Generator for VNS Therapy
Cyberonics Announces FDA Approval of Re-Designed AspireHC(TM) Generator for VNS Therapy
HSMN NewsFeed - 31 Oct 2011
Cyberonics Receives FDA Approval for Expansion of MRI Use With VNS Therapy(R) Systems
Cyberonics Receives FDA Approval for Expansion of MRI Use With VNS Therapy(R) Systems
HSMN NewsFeed - 24 Oct 2011
Cyberonics Announces Submission of AspireHC(TM) Generator for Regulatory Approvals
Cyberonics Announces Submission of AspireHC(TM) Generator for Regulatory Approvals
HSMN NewsFeed - 10 Oct 2011
Cyberonics Announces Resignation of James A. Reinstein, Senior Vice President & Chief Commercial Officer
Cyberonics Announces Resignation of James A. Reinstein, Senior Vice President & Chief Commercial Officer
HSMN NewsFeed - 1 Feb 2011
Cyberonics Announces FDA Approval of Aspire High Capacity Generator for VNS Therapy
Cyberonics Announces FDA Approval of Aspire High Capacity Generator for VNS Therapy
HSMN NewsFeed - 1 May 2007
Daniel J. Moore Appointed President and Chief Executive Officer of Cyberonics
Daniel J. Moore Appointed President and Chief Executive Officer of Cyberonics
HSMN NewsFeed - 18 Jul 2006
Cyberonics Receives FDA Real-Time Review Approval for New VNS Therapy Perennia Lead
Cyberonics Receives FDA Real-Time Review Approval for New VNS Therapy Perennia Lead
HSMN NewsFeed - 12 Jul 2006
Cyberonics Receives FDA Approval for Harmonized/Modularized VNS Therapy System Labeling Format
Cyberonics Receives FDA Approval for Harmonized/Modularized VNS Therapy System Labeling Format
Additional items found! 60
Members Archive contains
60 additional stories matching:
Cyberonics
(Password required)
Cyberonics
(Password required)